Cholangiocarcinoma: Epidemiology and Imaging-Based Review.
Kidanemariam S, Gu J, Yoon JH, Challapalli JV, Fruh V, Sax AJ.
R I Med J (2013). 2024 May 2;107(5):43-48.
Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S.
Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15.
Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology.
Mocchegiani F, Vincenzi P, Conte G, Nicolini D, Rossi R, Cacciaguerra AB, Vivarelli M.
World J Gastroenterol. 2023 Oct 14;29(38):5361-5373. doi: 10.3748/wjg.v29.i38.5361.
Diffuse Intrahepatic Bile Duct Hamartomas.
Peng T, Lu H, Deng L, Li Q, Chen K, Xia B.
Am J Gastroenterol. 2022 Apr 1;117(4):530. doi: 10.14309/ajg.0000000000001675.
Intrahepatic cholangiocarcinoma.
Brown KM, Parmar AD, Geller DA.
Surg Oncol Clin N Am. 2014 Apr;23(2):231-46. doi: 10.1016/j.soc.2013.10.004.
RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
Zhang C, Wang Y, Wu G, Sun N, Bai H, Li X, Han S, Zhou H, Qi R, Zhang J.
Biol Direct. 2024 Feb 23;19(1):16. doi: 10.1186/s13062-024-00453-6.
[Pathology of bile duct cancer].
Zen Y.
Nihon Shokakibyo Gakkai Zasshi. 2023;120(4):291-296. doi: 10.11405/nisshoshi.120.291.
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
Liu D, Heij LR, Czigany Z, Dahl E, Lang SA, Ulmer TF, Luedde T, Neumann UP, Bednarsch J.
J Exp Clin Cancer Res. 2022 Apr 7;41(1):127. doi: 10.1186/s13046-022-02340-2.
[Cholangiocarcinomas].
Schöning W, Haber PK, Pratschke J.
Chirurgie (Heidelb). 2025 Jan;96(1):77-86. doi: 10.1007/s00104-024-02200-z. Epub 2024 Dec 10.
Imaging of Intrahepatic Cholangiocarcinoma.
Mar WA, Chan HK, Trivedi SB, Berggruen SM.
Semin Ultrasound CT MR. 2021 Aug;42(4):366-380. doi: 10.1053/j.sult.2021.04.001. Epub 2021 Apr 20.
